IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

European Neuropsychopharmacology

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on June 27, 2025

Impact Score

2024-2025

4.89

h-Index

2024-2025

 136

Rank

2024-2025

 1538

SJR

2024-2025

 1.934

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title European Neuropsychopharmacology
Abbreviation Eur. Neuropsychopharmacol.
Publication Type Journal
Subject Area, Categories, Scope Biological Psychiatry (Q1); Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)
h-index 136
Overall Rank/Ranking 1538
SCImago Journal Rank (SJR) 1.934
Impact Score 4.89
Publisher Elsevier B.V.
Country Netherlands
ISSN 0924977X, 18737862
Best Quartile Q1
Coverage History 1990-2025




About European Neuropsychopharmacology


European Neuropsychopharmacology is a journal covering the technologies/fields/categories related to Biological Psychiatry (Q1); Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1). It is published by Elsevier B.V.. The overall rank of European Neuropsychopharmacology is 1538. According to SCImago Journal Rank (SJR), this journal is ranked 1.934. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 136. The best quartile for this journal is Q1.

The ISSN of European Neuropsychopharmacology journal is 0924977X, 18737862. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. European Neuropsychopharmacology is cited by a total of 1941 articles during the last 3 years (Preceding 2024).


European Neuropsychopharmacology Impact IF 2024-2025


The Impact IF 2024 of European Neuropsychopharmacology is 4.89, which is computed in 2025 as per its definition. European Neuropsychopharmacology IF is increased by a factor of 0.67 and approximate percentage change is 15.88% when compared to preceding year 2023, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

European Neuropsychopharmacology Impact IF 2025 Prediction


Impact IF 2024 of European Neuropsychopharmacology is 4.89. If the same upward trend persists, Impact IF may rise in 2025 as well.


Impact IF Trend


Year wise Impact IF of European Neuropsychopharmacology. Based on Scopus data.


Year Impact IF
2025/2026 Coming Soon
2024 4.89
2023 4.22
2022 4.62
2021 4.34
2020 3.66
2019 3.61
2018 4.32
2017 4.10
2016 4.52
2015 4.68
2014 4.44

European Neuropsychopharmacology h-index


  Table Setting

European Neuropsychopharmacology has an h-index of 136. It means 136 articles of this journal have more than 136 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




European Neuropsychopharmacology ISSN


The ISSN of European Neuropsychopharmacology is 0924977X, 18737862. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

European Neuropsychopharmacology Rank and SCImago Journal Rank (SJR)


The overall rank of European Neuropsychopharmacology is 1538. According to SCImago Journal Rank (SJR), this journal is ranked 1.934. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of European Neuropsychopharmacology by Year


Year SJR
2025/2026 Coming Soon
2024 1.934
2023 1.756
2022 1.442
2021 1.324
2020 1.603
2019 1.652
2018 1.911
2017 1.911
2016 2.085
2015 1.903
2014 2.209

Ranking of European Neuropsychopharmacology by Year


Year Ranking
2025/2026 Coming Soon
2024 1538
2023 1708
2022 2283
2021 2601
2020 2014
2019 1872
2018 1483
2017 1494
2016 1281
2015 1593
2014 1155

European Neuropsychopharmacology Publisher


Table Setting

European Neuropsychopharmacology is published by Elsevier B.V.. It's publishing house is located in Netherlands. Coverage history of this journal is as following: 1990-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of European Neuropsychopharmacology is Eur. Neuropsychopharmacol.. This abbreviation ('Eur. Neuropsychopharmacol.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in European Neuropsychopharmacology


If your research field is/are related to Biological Psychiatry (Q1); Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the European Neuropsychopharmacology?

European Neuropsychopharmacology latest impact IF is 4.89. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 4.89 (2024) and 3.61 (2019), respectively, in the last 11 years. Moreover, its average IS is 4.31 in the previous 11 years.


What's the SCImago Journal Rank (SJR) of the European Neuropsychopharmacology?

The European Neuropsychopharmacology has an SJR (SCImago Journal Rank) of 1.934, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 2.209 in 2014 and the lowest being 1.324 in 2021. Furthermore, the average SJR of the European Neuropsychopharmacology over the previous 11-year period stands at 4.31.


What's the latest h-index of the European Neuropsychopharmacology?

The latest h-index of the European Neuropsychopharmacology is 136.


Who's the publisher of the European Neuropsychopharmacology?

The European Neuropsychopharmacology is published by the Elsevier B.V., with its country of publication being the Netherlands.


What's the current ranking of the European Neuropsychopharmacology?

The European Neuropsychopharmacology is currently ranked 1538 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 1155 in 2014 and its lowest position of 2601 in 2021.


What's the abbreviation or short name for the European Neuropsychopharmacology?

The standard ISO4 abbreviation for the European Neuropsychopharmacology is Eur. Neuropsychopharmacol..


Is the "European Neuropsychopharmacology" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

European Neuropsychopharmacology is classified as a journal that the Elsevier B.V. publishes.


What's the scope or major areas of the European Neuropsychopharmacology?

The European Neuropsychopharmacology encompasses the following areas:

  • Biological Psychiatry
  • Neurology
  • Neurology (clinical)
  • Pharmacology
  • Pharmacology (medical)
  • Psychiatry and Mental Health

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the European Neuropsychopharmacology?

The European Neuropsychopharmacology is assigned the following International Standard Serial Numbers (ISSN): 0924977X, 18737862.


What's the best quartile of the European Neuropsychopharmacology?

The best quartile for the European Neuropsychopharmacology is Q1 (2024).


What's the coverage history of the European Neuropsychopharmacology?

The European Neuropsychopharmacology coverage history can be summarized as follows: 1990-2025.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Journal of Field Archaeology journal 7683 Maney Publishing 48 1.85
Applied Ecology and Environmental Research journal 19122 Corvinus University of Budapest 48 0.84
Qualitative Research journal 1300 SAGE Publications Ltd 101 6.77
Clinical Medicine and Research journal 14921 Marshfield Clinic 64 1.25
Entrepreneurship Theory and Practice journal 168 SAGE Publications Ltd 212 13.35
Archives of Phytopathology and Plant Protection journal 16692 Taylor and Francis Ltd. 35 1.42
Materials Research journal 15597 Universidade Federal de Sao Carlos 75 1.40
Abacus journal 11890 Wiley-Blackwell Publishing Ltd 56 2.95
Journal, Indian Academy of Clinical Medicine journal 28559 Indian Academy of Clinical Medicine 16 0.10
Tekstilec trade journal 17340 University of Ljubljana Press 16 1.29

Check complete list




Year wise Impact Score (IS) of European Neuropsychopharmacology

Impact Score Table

Year Impact Score (IS)
2025/2026 Coming Soon
2024 4.89
2023 4.22
2022 4.62
2021 4.34
2020 3.66
2019 3.61
2018 4.32
2017 4.10
2016 4.52
2015 4.68
2014 4.44



Top Journals/Conferences in Biological Psychiatry

Lancet Psychiatry,The
Elsevier Ltd | United Kingdom

Biological Psychiatry
Elsevier Inc. | United States

Nature Mental Health
Springer Nature | United Kingdom

Translational Psychiatry
Springer Nature | United Kingdom

Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
Elsevier Inc. | United States

Journal of Abnormal Psychology
American Psychological Association | United States

Brain Communications
Oxford University Press | United States

Progress in Neuro-Psychopharmacology and Biological Psychiatry
Elsevier Inc. | United States

Psychiatry Research
Elsevier Ireland Ltd | Ireland

European Archives of Psychiatry and Clinical Neuroscience
D. Steinkopff-Verlag | Germany

See All

Top Journals/Conferences in Neurology

Lancet Neurology, The
Elsevier Ltd | United Kingdom

Neuro-Oncology
Oxford University Press | United Kingdom

JAMA Neurology
American Medical Association | United States

Nature Reviews Neurology
Nature Research | United Kingdom

Molecular Neurodegeneration
BioMed Central Ltd | United Kingdom

Brain
Oxford University Press | United Kingdom

Acta Neuropathologica
Springer Science and Business Media Deutschland GmbH | Germany

Ageing Research Reviews
Elsevier Ireland Ltd | Ireland

Sleep Medicine Reviews
W.B. Saunders Ltd | United Kingdom

Translational Neurodegeneration
BioMed Central Ltd | United Kingdom

See All

Top Journals/Conferences in Neurology (clinical)

Lancet Neurology, The
Elsevier Ltd | United Kingdom

Neuro-Oncology
Oxford University Press | United Kingdom

JAMA Neurology
American Medical Association | United States

Nature Reviews Neurology
Nature Research | United Kingdom

Molecular Neurodegeneration
BioMed Central Ltd | United Kingdom

Brain
Oxford University Press | United Kingdom

Acta Neuropathologica
Springer Science and Business Media Deutschland GmbH | Germany

Sleep Medicine Reviews
W.B. Saunders Ltd | United Kingdom

Translational Neurodegeneration
BioMed Central Ltd | United Kingdom

Annals of Neurology
John Wiley & Sons Inc. | United States

See All

Top Journals/Conferences in Pharmacology

Nature Reviews Drug Discovery
Nature Research | United Kingdom

Pharmacological Reviews
Elsevier Inc. | United States

Drug Resistance Updates
Churchill Livingstone | United Kingdom

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

Annual Review of Pharmacology and Toxicology
Annual Reviews Inc. | United States

Molecular Therapy
Cell Press | United States

Pharmacology and Therapeutics
Elsevier Inc. | United States

Trends in Pharmacological Sciences
Elsevier Ltd | United Kingdom

Acta Pharmaceutica Sinica B
Chinese Academy of Medical Sciences | China

Theranostics
Ivyspring International Publisher | Australia

See All

Top Journals/Conferences in Pharmacology (medical)

Drug Resistance Updates
Churchill Livingstone | United Kingdom

Pharmacology and Therapeutics
Elsevier Inc. | United States

Drugs
| Switzerland

Journal of Biomedical Science
BioMed Central Ltd | United Kingdom

npj Breast Cancer
Nature Publishing Group | United Kingdom

Alimentary Pharmacology and Therapeutics
John Wiley and Sons Inc | United Kingdom

American Journal of Transplantation
Elsevier B.V. | Netherlands

Acta Pharmacologica Sinica
Springer Nature | United Kingdom

BioDrugs
| Switzerland

npj Vaccines
Nature Publishing Group | United Kingdom

See All

Top Journals/Conferences in Psychiatry and Mental Health

World Psychiatry
Wiley-Blackwell | United States

Annual Review of Clinical Psychology
Annual Reviews Inc. | United States

Lancet Psychiatry,The
Elsevier Ltd | United Kingdom

Clinical Psychology Review
Elsevier Inc. | United States

JAMA Psychiatry
American Medical Association | United States

American Journal of Psychiatry
American Psychiatric Association | United States

Lancet Healthy Longevity, The
Elsevier Ltd | United Kingdom

Psychotherapy and Psychosomatics
S. Karger AG | Switzerland

Health Psychology Review
Routledge | United Kingdom

Molecular Psychiatry
Springer Nature | United Kingdom

See All